Post Categories
Blog post not found!
Resiliency in CRO Operations During the COVID-19 Pandemic
A Conversation with QPS Holdings LLC Chairman, President and Chief Executive Officer, Ben Chien, PhD NOVEMBER 2020 As QPS Holdings LLC Chairman President, and…
Resiliency in CRO Operations During the COVID-19 Pandemic
November 23, 2020
A Conversation with QPS Holdings LLC Chairman, President and Chief Executive Officer, Ben Chien, PhD NOVEMBER 2020 As QPS Holdings LLC Chairman President, and…
What Field Researchers Can Teach Us About Quarantine and Isolation
As countries around the world move through various stages of quarantine and restrictions on public life, many people are finding themselves more isolated than…

What Field Researchers Can Teach Us About Quarantine and Isolation
November 16, 2020
As countries around the world move through various stages of quarantine and restrictions on public life, many people are finding themselves more isolated than…
QPS COVID-19 Testing Capabilities
The COVID-19 pandemic has been a call to arms for many of the world’s biotech and pharmaceutical companies. Although progress has been made, these…

QPS COVID-19 Testing Capabilities
November 11, 2020
The COVID-19 pandemic has been a call to arms for many of the world’s biotech and pharmaceutical companies. Although progress has been made, these…
Gene Therapy and Inherited Retinal Diseases
Inherited retinal diseases (IRDs) can cause vision loss that ranges from mild to severe, and can even cause blindness. These diseases affect people of…

Gene Therapy and Inherited Retinal Diseases
November 9, 2020
Inherited retinal diseases (IRDs) can cause vision loss that ranges from mild to severe, and can even cause blindness. These diseases affect people of…
Oligonucleotides: Innovations in Antivirals for Novel Viruses
As scientists, doctors and researchers race to develop vaccines and therapeutics for SARS-CoV-2, several drugs have emerged as promising candidates. Oligonucleotide therapeutics are one…

Oligonucleotides: Innovations in Antivirals for Novel Viruses
November 2, 2020
As scientists, doctors and researchers race to develop vaccines and therapeutics for SARS-CoV-2, several drugs have emerged as promising candidates. Oligonucleotide therapeutics are one…
UK COVID-19 Challenge Trials to Infect Healthy Volunteers with Coronavirus
As communities strive to prevent the spread of SARS-CoV-2, the virus that causes COVID-19, the United Kingdom is funding research trials that will deliberately…

UK COVID-19 Challenge Trials to Infect Healthy Volunteers with Coronavirus
October 29, 2020
As communities strive to prevent the spread of SARS-CoV-2, the virus that causes COVID-19, the United Kingdom is funding research trials that will deliberately…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…